ArticleJournal of the American Geriatrics Society2019
Reply to: Comment on: Serum Cholesterol and Incident Alzheimer's Disease: Findings From the Adult Changes in Thought Study.
Zachary A Marcum, Rod Walker, Jennifer F Bobb, Mo-Kyung Sin, Shelly L Gray, James D Bowen, Wayne McCormick, Susan M McCurry, Paul K Crane, Eric B Larson
Abstract readLetterComment
In one paragraphArticle in Journal of the American Geriatrics Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors.
Zachary A MarcumDepartment of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.ORCID 0000-0002-4690-2304 Rod WalkerKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Jennifer F BobbKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Mo-Kyung SinCollege of Nursing, Seattle University, Seattle, Washington.
Shelly L GrayDepartment of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.
James D BowenSwedish Medical Center, Seattle, Washington.
Wayne McCormickDepartment of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, Washington.
Susan M McCurrySchool of Nursing, University of Washington, Seattle, Washington.
Paul K CraneDepartment of Medicine, Division of General Internal Medicine, University of Washington, Seattle, Washington.
Eric B LarsonKaiser Permanente Washington Health Research Institute, Seattle, Washington.
Funding
Furthering scientific understanding of mechanisms underlying resilience to the effects of AD pathology by incorporating state of the art quantification of gliosis, inflammation, & synaptic toxicityU01AG006781 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K, LARSON, ERIC B · 1986 to 2020
$39.3MUW Patient-Centered Outcomes Research Career Development Program K12 2014 2019K12HS022982 · AHRQ · UNIVERSITY OF WASHINGTON · PI SULLIVAN, SEAN D · 2014 to 2018
$3.8MAgency for Healthcare Research and Quality K12HS022982AHRQ HHS K12 HS022982NIA NIH HHS U01 AG006781NIA NIH HHS U01AG006781
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Alzheimer DiseaseCholesterolHumansRisk FactorsCholesterol
Identifiers
PMID30893465
PMCPMC6561793
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390